We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$2.21B
AUM Growth
+$812M
Cap. Flow
+$742M
Cap. Flow %
33.62%
Top 10 Hldgs %
27.71%
Holding
247
New
68
Increased
117
Reduced
29
Closed
5

Sector Composition

Rank Sector Weight
1 Financials 17.62%
2 Technology 16.59%
3 Healthcare 9.57%
4 Consumer Discretionary 8.77%
5 Consumer Staples 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
226
Citigroup
C
$221B
$210K 0.01%
+3,003
New +$201K
PEG icon
227
Public Service Enterprise Group
PEG
$39.5B
$207K 0.01%
+3,511
New +$209K
CMF icon
228
iShares California Muni Bond ETF
CMF
$4.56B
$206K 0.01%
3,400
NEE icon
229
NextEra Energy
NEE
$186B
$204K 0.01%
+3,992
New +$196K
UMH
230
UMH Properties
UMH
$1.35B
$172K 0.01%
13,896
APHA
231
DELISTED
Aphria Inc. Common Shares
APHA
$154K 0.01%
22,000
F icon
232
Ford
F
$59.1B
$118K 0.01%
11,500
AGEN
233
Agenus
AGEN
$266M
$99K ﹤0.01%
1,678
NOK icon
234
Nokia
NOK
$49.3B
$70K ﹤0.01%
+14,000
New +$73.7K
HOLX
235
DELISTED
Hologic
HOLX
$66K ﹤0.01%
33,204
+646
+2% +$29.9K
FSTX
236
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$57K ﹤0.01%
+3,829
New +$103K
DAKT icon
237
Daktronics
DAKT
$954M
$41K ﹤0.01%
40,989
PTN
238
Palatin Technologies
PTN
$13.4M
$29K ﹤0.01%
20
VRDN icon
239
Viridian Therapeutics
VRDN
$2.14B
$25K ﹤0.01%
+800
New +$32.1K
CATX icon
240
Perspective Therapeutics
CATX
$328M
$22K ﹤0.01%
5,482
CFRX
241
DELISTED
ContraFect Corporation
CFRX
$7K ﹤0.01%
17
APO icon
242
Apollo Global Management
APO
$71.5B
-8,295
Closed -$234K
NVAX icon
243
Novavax
NVAX
$1.21B
-2,245
Closed -$25K
VTI icon
244
Vanguard Total Stock Market ETF
VTI
$656B
-4,036
Closed -$584K
AMJ
245
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
-595,553
Closed -$15.2M
MLPI
246
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
-409,365
Closed -$9.3M

Similar funds

Crestwood Advisors Group's Q2 2019 Portfolio in Review

As of Q2 2019, Crestwood Advisors Group held 247 positions worth $2.21B, up 58% from $1.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Crestwood Advisors Group deployed $742M of net new capital in Q2 2019, opening 68 new positions and adding to 117 existing holdings. Its largest new stake was Fiserv Inc: 235,180 shares worth $21.4M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was 3M, an estimated $15.7M trimmed.

  • Crestwood Advisors Group's largest Q2 2019 buy was Fiserv Inc: 235,180 shares worth $21.4M.
  • Crestwood Advisors Group added most to Amazon in Q2 2019, an estimated $48.6M increase.
  • Crestwood Advisors Group's biggest Q2 2019 reduction was 3M, cutting an estimated $15.7M.
  • Crestwood Advisors Group fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2019, selling an estimated $15.2M.
  • Crestwood Advisors Group's ten largest holdings make up 28% of its $2.21B portfolio in Q2 2019.
  • Crestwood Advisors Group opened 68 new positions and closed 5 in Q2 2019.
  • Crestwood Advisors Group's portfolio value rose 58% quarter-over-quarter to $2.21B.

Based on Crestwood Advisors Group's 13F filing for Q2 2019, filed 14 Aug 2019.